Teclistamab (Tecvayli) is an off-the-shelf first-in-class bispecific monoclonal antibody shown in the MajesTEC-1 trial to ...
Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and ...
But even before the auction, CSK have made decisive moves about its leadership group within the side: trading Ravindra Jadeja ...
MSD in the Philippines President and Managing Director Andreas Riedel, Vaccines Business Unit Director Ethel Calma, and the ...
Australian researchers have worked with global phamarceutical company MSD to co-develop a new antimalarial drug candidate ...
Merck Sharp & Dohme (MSD) has agreed to acquire Cidara Therapeutics in a transaction valued at approximately $9.2 billion, following encouraging results from the company’s phase 2b trial of its lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback